Brief: Neurophet Secures FDA 510(K) Clearance For "Neurophet Aqua Ad Plus," Marking Its Third U.S. Regulatory Milestone06/02/2026 14:04
Brief: Neurophet Signs MoU With Inrad To Establish Global Standards For Alzheimer's Disease And Dementia Data02/09/2025 17:49
Last trade - 00:00Last trade - 00:00Last trade - 00:00